Ebenbuild

Healthcare Software · Germany · 1-10 Employees

View Company Info for Free

Overview

Headquarters

Holzstr. 28, Munich, Bavaria, 80469, Ger...

Phone Number

+49 8921525477

Revenue

<$5 Million

Industry

Healthcare Software Software Software Testing Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1

About Ebenbuild

Ebenbuild specializes in precision therapy through personalized digital twins, focusing on pulmonary care. Their innovative technology combines advanced physics-based modeling with patient-specific data to create virtual replicas of individual lungs, enabling clinicians to simulate ventilation strategies and optimize drug delivery. The company's applications include Aerogram for actionable insights in ventilation and Twinhale for in silico trials in respiratory drug delivery. Ebenbuild aims to fundamentally change the understanding and treatment of lung conditions.Explore more
Ebenbuild's Social MediaPopular SearchesEbenbuild GmbHEbenbuildSIC Code 73,737NAICS Code 54,541Show more

Is Ebenbuild your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Software companies

Low Activity

High Activity

Activity Insights

Ebenbuild is experiencing very low activity levels compared to other companies in the Software sector.

What does this means?

Ebenbuild is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Ebenbuild.

Ebenbuild Tech Stack

A closer look at the technologies used by Ebenbuild

Ebenbuild News & Media

  • Ebenbuild Secures Euro 2.3 Million EIC Grant to Scale Digital Twin Platform for Respiratory Health

    Munich, Germany – July 2, 2025 -- Ebenbuild, a company developing personalized, AI-enabled digital twins of lungs to support clinical decisions and digital clinical trials, today announced that it has received Euro 2.3 million funding under the European Innovation Council (EIC) Accelerator program to advance its digital twin platform technology. In addition, the EIC fund will invest up to €10 million in future equity financing rounds raised by Ebenbuild. The funding will support the market
  • Ebenbuild Contributes Cutting-Edge Digital Lung Simulations to Pulmonary Fibrosis Drug Development

    Munich, Germany – April 9, 2025 -- Ebenbuild, a company developing personalized, AI-enabled digital twins of lungs to support clinical decisions and digital clinical trials, today announced its contribution to a pioneering study published today in Nature Communications. The article titled Preclinical concept studies showing advantage of an inhaled anti-CTGF/CCN2 protein for pulmonary fibrosis treatment (DOI:10.1038/s41467-025-58568-x) highlights the potential of inhaled therapeutics for treating
  • Ebenbuild Appoints Charles A. Taylor, PhD as Chairman of the Board

    Munich, Germany, November 11, 2024 -- Ebenbuild, a company developing personalized, AI-enabled digital twins of lungs to support clinical decisions and digital clinical trials, today announced that Charles A. Taylor, PhD has been appointed Chairman of the Board. Dr. Taylor is a pioneer in the field of predictive, simulation-based medicine where he applied computational fluid dynamics to predict outcomes of cardiovascular interventions in individual patients.
  • Ebenbuild to Receive Public Funding Under UBIC Consortium for Digital Lung Twin Project

    Munich, Germany, November 28, 2023 -- Ebenbuild, a company developing personalized, AI-driven virtual lungs to support clinical decisions and digital clinical trials, today announced its participation in the research project Personalized Lung Twins for the Treatment of Acute Respiratory Distress Syndrome (UBIC) in collaboration with the University Hospital Schleswig-Holstein, Augsburg University Hospital, University Hospital Carl Gustav Carus Dresden, University Hospital RWTH Aachen and Universi
Read more news

Top Healthcare Software Companies

Frequently Asked Questions Regarding Ebenbuild

What is Ebenbuild's official website?
Ebenbuild's official website is www.ebenbuild.com
What is Ebenbuild's Revenue?
Ebenbuild's revenue is <$5 Million
What is Ebenbuild's SIC code?
Ebenbuild's SIC: 73,737
What is Ebenbuild's NAICS code?
Ebenbuild's NAICS: 54,541
How many employees does Ebenbuild have?
Ebenbuild has 1-10 employees
What industry does Ebenbuild belong to?
Ebenbuild is in the industry of: Healthcare Software, Software, Software Testing
What technology does Ebenbuild use?
Some of the popular technologies that Ebenbuild uses are: Google Font API, YouTube, Java, Python
How do I contact Ebenbuild?
Ebenbuild contact info: Phone number: +49 8921525477 Website: www.ebenbuild.com
What does Ebenbuild do?

Ebenbuild specializes in precision therapy through personalized digital twins, focusing on pulmonary care. Their innovative technology combines advanced physics-based modeling with patient-specific data to create virtual replicas of individual lungs, enabling clinicians to simulate ventilation strategies and optimize drug delivery. The company's ap... plications include Aerogram for actionable insights in ventilation and Twinhale for in silico trials in respiratory drug delivery. Ebenbuild aims to fundamentally change the understanding and treatment of lung conditions.Read More

What are Ebenbuild social media links?
Ebenbuild Linkedin page Ebenbuild Twitter page
Is Ebenbuild a public company?
Ebenbuild is private company therefore does not currently have an official ticker symbol
See more information about Ebenbuild

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.